160 related articles for article (PubMed ID: 38334760)
1. Association of peritumoral region features assessed on breast MRI and prognosis of breast cancer: a systematic review and meta-analysis.
Zhao S; Li Y; Ning N; Liang H; Wu Y; Wu Q; Wang Z; Tian J; Yang J; Gao X; Liu A; Song Q; Zhang L
Eur Radiol; 2024 Feb; ():. PubMed ID: 38334760
[TBL] [Abstract][Full Text] [Related]
2. Peritumoral ADC values in breast cancer: region of interest selection, associations with hyaluronan intensity, and prognostic significance.
Kettunen T; Okuma H; Auvinen P; Sudah M; Tiainen S; Sutela A; Masarwah A; Tammi M; Tammi R; Oikari S; Vanninen R
Eur Radiol; 2020 Jan; 30(1):38-46. PubMed ID: 31359124
[TBL] [Abstract][Full Text] [Related]
3. Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes.
Igarashi T; Furube H; Ashida H; Ojiri H
Eur J Radiol; 2018 Oct; 107():111-118. PubMed ID: 30292254
[TBL] [Abstract][Full Text] [Related]
4. Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
Okuma H; Sudah M; Kettunen T; Niukkanen A; Sutela A; Masarwah A; Kosma VM; Auvinen P; Mannermaa A; Vanninen R
PLoS One; 2020; 15(6):e0235278. PubMed ID: 32584887
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
Choi EJ; Youk JH; Choi H; Song JS
J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
[TBL] [Abstract][Full Text] [Related]
6. The application of apparent diffusion coefficients derived from intratumoral and peritumoral zones for assessing pathologic prognostic factors in rectal cancer.
Yuan Y; Chen XL; Li ZL; Chen GW; Liu H; Liu YS; Pang MH; Liu SY; Pu H; Li H
Eur Radiol; 2022 Aug; 32(8):5106-5118. PubMed ID: 35320412
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. High Peritumoral and Intratumoral T2 Signal Intensity in HER2-Positive Breast Cancers on Preneoadjuvant Breast MRI: Assessment of Associations With Histopathologic Characteristics.
Jirarayapong J; Portnow LH; Chikarmane SA; Lan Z; Gombos EC
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330280. PubMed ID: 38117101
[No Abstract] [Full Text] [Related]
9. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis.
Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH
J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner.
Panzironi G; Moffa G; Galati F; Marzocca F; Rizzo V; Pediconi F
Breast Cancer Res Treat; 2020 May; 181(1):53-60. PubMed ID: 32185587
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast enhanced-MRI and diffusion-weighted image as predictors of lymphovascular invasion in node-negative invasive breast cancer.
Choi BB
World J Surg Oncol; 2021 Mar; 19(1):76. PubMed ID: 33722246
[TBL] [Abstract][Full Text] [Related]
12. Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer.
Mori N; Mugikura S; Takasawa C; Miyashita M; Shimauchi A; Ota H; Ishida T; kasajima A; Takase K; Kodama T; Takahashi S
Eur Radiol; 2016 Feb; 26(2):331-9. PubMed ID: 26024846
[TBL] [Abstract][Full Text] [Related]
13. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
Chen H; Li W; Wan C; Zhang J
Front Oncol; 2022; 12():942943. PubMed ID: 35992872
[TBL] [Abstract][Full Text] [Related]
14. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
[TBL] [Abstract][Full Text] [Related]
15. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tumor and adjacent peritumoral stroma in patients with breast cancer using high-resolution diffusion-weighted imaging: Correlation with pathologic biomarkers.
Shin HJ; Park JY; Shin KC; Kim HH; Cha JH; Chae EY; Choi WJ
Eur J Radiol; 2016 May; 85(5):1004-11. PubMed ID: 27130063
[TBL] [Abstract][Full Text] [Related]
17. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
[TBL] [Abstract][Full Text] [Related]
18. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
[TBL] [Abstract][Full Text] [Related]
19. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
20. The value of adjacent vessel sign in malignant breast tumors.
Çetinkaya E; Yıldız Ş; Otçu H; Sharifov R; Çelik Yabul F; Alkan A
Diagn Interv Radiol; 2022 Sep; 28(5):463-469. PubMed ID: 35997479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
